Biogen: Balancing Risks And Opportunities
Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...
Biogen plots new global headquarters in Kendall Square
The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development ...
The Harvard Crimson4 天
Biogen to Move Global Headquarters to Kendall Commons in 2028
Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...
The US approved an Alzheimer’s drug. Seven patients subsequently died.
Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...
Biogen to move HQ to new tower in MIT Kendall development
Biogen Inc. plans to move its headquarters into a 16-story Kendall Square tower to be developed by MIT and BioMed Realty ...
Biogen announces plans for new global HQ, innovation hub at Kendall Common
Biogen (BIIB) announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year ...
PharmiWeb6 天
Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square
Biogen Inc. (Nasdaq: BIIB) announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in ...
Yahoo Finance7 天
Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square
Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its Massachusetts real estate footprint New building will be ...